NEXT Financial Holdings’s iShares Biotechnology ETF IBB Stock Holding History

NEXT Financial Holdings’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	$528K	Buy	+4,722	New	+$518K	0.13%	106

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

DFO

Duquesne Family Office New York $3.38B AUM 61.92% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Natixis Paris, France $28B AUM 26.79% 1-Year Est. Return

NEXT Financial Holdings's IBB Position: Q1 2019 in Review

NEXT Financial Holdings opened a new position in iShares Biotechnology ETF (IBB) in Q1 2019: 4,722 shares worth $528K. The stake represents 0.13% of the portfolio and ranks #106 among its holdings.

670 funds tracked by Wall St. Rank hold IBB as of Q1 2019.

NEXT Financial Holdings held 4,722 shares of iShares Biotechnology ETF worth $528K as of Q1 2019.
iShares Biotechnology ETF was a new NEXT Financial Holdings position in Q1 2019.
iShares Biotechnology ETF made up 0.13% of NEXT Financial Holdings's portfolio in Q1 2019, its #106 holding.
670 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2019.

Based on NEXT Financial Holdings's 13F filing for Q1 2019, filed 13 May 2019.